Content
06/13/2024
San Diego, CA USA
Alida Biosciences
completed $7.5 million Series A Round funding. Investors include
Genoa Ventures (lead), Vertical Venture Partners, FusionX Ventures.
About
Alida Biosciences is developing the next generation of RNA analysis tools to enable new medical treatments and diagnostic assays.
Startup
Sector:
Biotech
Download StockFan App
Ad
Stock market data, news and community, all integrated.
Features include real time stock quotes, interactive charts, technical signals, institutional & insider ownerships, stock screener, ETF rankings, SEC filings, press releases, videos, earnings calendar, social media posts, group chats.
